Toronto Dominion Bank raised its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 68.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 62,779 shares of the company’s stock after purchasing an additional 25,474 shares during the quarter. Toronto Dominion Bank owned approximately 0.05% of Henry Schein worth $4,577,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. American Century Companies Inc. boosted its holdings in shares of Henry Schein by 3.1% in the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after buying an additional 162,477 shares during the last quarter. FMR LLC raised its position in Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after acquiring an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP lifted its stake in Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after acquiring an additional 600,000 shares during the last quarter. Nuance Investments LLC grew its position in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after acquiring an additional 414,748 shares during the period. Finally, Burgundy Asset Management Ltd. increased its stake in shares of Henry Schein by 1.0% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock worth $105,148,000 after purchasing an additional 16,476 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on HSIC. Evercore ISI raised their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Barrington Research reissued an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and a consensus target price of $78.89.
Henry Schein Stock Down 0.6 %
HSIC stock opened at $76.60 on Friday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a market capitalization of $9.55 billion, a price-to-earnings ratio of 31.52, a PEG ratio of 2.31 and a beta of 0.87. The business’s fifty day moving average price is $72.25 and its two-hundred day moving average price is $70.06.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the firm earned $1.32 earnings per share. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. On average, equities analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current year.
Insider Transactions at Henry Schein
In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.14% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
- Five stocks we like better than Henry Schein
- Using the MarketBeat Dividend Yield Calculator
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Basic Materials Stocks Investing
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.